ERBB2 and breast cancer: HRG enhances cell migration by modifying cell morphology and rearranging the actin cytoskeleton in HER2-positive breast cancer cells, involving numerous kinases and scaffolding proteins, including c-Src, FAK, paxillin, PAK1, cortactin, and N-WASP.